Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
In plasmodia, the dihydrofolate reductase (DHFR) enzyme is the target of the pyrimethamine component of sulfadoxine-pyrimethamine (S/P). Plasmodium vivax infections are not treated intentionally with antifolates. However, outside Africa, coinfections with Plasmodium falciparum and P. vivax are commo...
Prif Awduron: | Hastings, MD, Maguire, J, Bangs, M, Zimmerman, P, Reeder, J, Baird, J, Sibley, C |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2005
|
Eitemau Tebyg
-
Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
gan: Hastings, MD, et al.
Cyhoeddwyd: (2004) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
gan: Imwong, M, et al.
Cyhoeddwyd: (2001) -
<it>Plasmodium vivax dhfr </it>and <it>dhps </it>mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine
gan: Jahevitra Martial, et al.
Cyhoeddwyd: (2008-02-01) -
Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.
gan: Certain, L, et al.
Cyhoeddwyd: (2008) -
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
gan: Imwong, M, et al.
Cyhoeddwyd: (2002)